Showing results (611-620 of 732) with videos related to

Sort By:
Pageof 74
Gastroenterology|August 31, 2011
Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14⁺ macrophagesRaja Atreya, Michael Zimmer, Brigitte Bartsch, et al.
Cell Death & Disease|January 13, 2022
SMYD2 targets RIPK1 and restricts TNF-induced apoptosis and necroptosis to support colon tumor growthYu-Qiang Yu, Veronika Thonn, Jay V Patankar, et al.
BMC Cancer|September 14, 2018
Effects of whole-body electromyostimulation combined with individualized nutritional support on body composition in patients with advanced cancer: a controlled pilot trialKristin Schink, Hans J Herrmann, Raphaela Schwappacher, et al.
Journal of Clinical Medicine|February 7, 2020
Extent of Mucosal Inflammation in Ulcerative Colitis Influences the Clinical Remission Induced by VedolizumabPatrizio Scarozza, Irene Marafini, Federica Laudisi, et al.
Endoscopy|May 15, 2024
A computer-aided detection system in the everyday setting of diagnostic, screening, and surveillance colonoscopy: an international, randomized trialMichiel H J Maas, Timo Rath, Cristiano Spada, et al.
Frontiers in Immunology|November 8, 2019
Citrullination Licenses Calpain to Decondense Nuclei in Neutrophil Extracellular Trap FormationStefanie Gößwein, Aylin Lindemann, Aparna Mahajan, et al.
Nature Communications|February 3, 2024
Etrolizumab-s fails to control E-Cadherin-dependent co-stimulation of highly activated cytotoxic T cellsMaximilian Wiendl, Mark Dedden, Li-Juan Liu, et al.
The Journal of Experimental Medicine|February 19, 2004
Specific regulation of T helper cell 1-mediated murine colitis by CEACAM1Hideki Iijima, Markus F Neurath, Takashi Nagaishi, et al.
Frontiers in Oncology|May 16, 2022
Glucose-Restricted Diet Regulates the Tumor Immune Microenvironment and Prevents Tumor Growth in Lung AdenocarcinomaAlexander Gähler, Denis I Trufa, Mircea T Chiriac, et al.
Inflammatory Bowel Diseases|May 12, 2026
Targeting the transcription factor GATA3 by the DNAzyme formulation SB012 in patients with moderately-to-severely active ulcerative colitis: a multicenter, randomized, placebo-controlled, phase 2a induction trialRaja Atreya, Tanja Kühbacher, Michael Vieth, et al.
Pageof 74